Case File
efta-02362584DOJ Data Set 11OtherEFTA02362584
Date
Unknown
Source
DOJ Data Set 11
Reference
efta-02362584
Pages
8
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Barrett, Paul
Sent:
Tuesday, May 1, 2012 8:04 PM
To:
Epstein, Jeffrey (jeevacation@gmail.com)
Cc:
Giuffrida, David
Subject:
RE: $2.59mm of WAMU 04-AR3 B2 @ 62-16 (10% yield / 6.26 durn)
=body lang="EN-US" link="blue" vlink="purple">
Jeffre=
We have 1.8MM cash in the Haze Trust. I would l=ke to spend $1MM on this mortgage and 800K on a new oil trust
coming out=2E Will walk you through the details.
=OD
Also we have $3MM=of the Chevron Market Plus note that will likely pay out a 10.6% coupon =n mid May. Underlying
was up 5%. So did well. Will look for some =OA ideas for the $3.3MM.
Paul
=OA
&nbs=;
Paul Barrett, CFA
=OA
Managing Director
Global Investment Opportunities Group
=p class="MsoNormal">JPMorgan Private Bank
320 Park Avenue, 14th Floor, New York, NY 10022=/p>
EFTA_R1_01355518
EFTA02362584
NMLS ID# 853441
=OD
=nbsp;
From: Barrett, Paul S =OA
Sent: Tuesday, May 01, 2012 3:54 PM
To: =Epstein, Jeffrey (jeevacation@gmail.com)
Cc: Giuffrida, =avid J
Subject: $2.59mm of WAMU 04-AR3 62 @ 62.16 (10% y=eld / 6.26 durn)
Jeffrey
Found a bond for the $1MM we were look=ng to spend from last week.
- &nbs=;
HPI Updated LTV = 58.53%
-
&nbs=; 85% of the borrowers have not missed a payment in the past 2 =ears
-&n=sp;
96% owner occupied=span style="font-size:10.0pt;font-family:"Calibri","san=-serir;color:#1F497D">
97 months season=d
WAMU 2004-AR3 62 Offered @ 62-16</=pan>
=OD
=OD
=0D
BOND DESCRIPTION
=span style="font-size:9.0pt;font-family:"Arial","sans-s=rif";color:black">Prepay Rate
<=d width="153" nowrap="" valign="bottom" style="width:114.45pt;ba=kground:f1F2F2F2;padding:0in 5.4pt Oin
5.4pt;height:15.75pt">
6 CPR
=0 ramp 30 8 CPR
Cusip:
92922FNM6<=span>
=OD
Default Rate<=:p>
2
EFTA_R1_01355519
EFTA02362585
1 ramp 36 3 1 CDR
0.75 ramp 36 =.25 0.5 CDR
Original Face:
2,590,000
Default=Severity
30
30 ramp 48 25
=OD
Current Face:4=pan>
=OD
<=pan style="font-size:9.Optfont-family:"Aria)","sans-se=if";color:#1F497D">1,888,737
<=d width="228" nowrap="" valign="bottom" style="width:171.25ptpa=ding:0in 5.4pt 0in 5.4ptheight:14.15pt">
Prime 5/1 Sub
=OD
Stress Caseq=pan>
=OA
<=pan style="font-size:9.0pt;font-family:"Arial","sans-se=if";color:black">Base Case
=td width="175" nowrap="" valign="bottom" style="width:131.05pt;b=rder-top:solid windowtext 1.0pt;border-
left:none;border-bottom:none;bord=r-right:solid windowtext 1.0pt;background:#BFBFBF;padding:0in 5.4pt 0i=
5.4ptheight:14.15pt">
Recovery Case
CCC/Ca/-=/o:p>
Yield
4.518
=0A10.001=o:p>
=urrent Coupon:
2.586%
=OA
Spread
3
EFTA_R1_01355520
EFTA02362586
274
816
=0D 1061</=:p>
=OD =OD
Yield @ Base Case
10.001%
=OD
apan style="font-size:9.0ptfont-family:"Arial","sans-se=if";color:black">6.71
6.26
WAL @ Base Case
9.58
=OA
=OAWAL=/o:p>
9.28
9.58<=p>
Pr=ncipal Window @ Base Case
Jun12 to Apr34
Principal Window
Jun12 to Apr34
Jun12 to Apr34
atd> Jun12 to May34
Writedown %
=/td> 11.39%
Principal Writedown
52.29%</=:p>
11.39%
=0A=.00%
2.30%
4
EFTA_R1_01355521
EFTA02362587
=0D
Total Collat Loss=/o:p>
1.11%
=0A=.80%
0.51%
=OA
60+ Delinquencies
5.38
=OD
Total Liquidation
=0A=0.08%
6.95%
=OD 3.78%
60+ Delinquency Coverage
</=d>
=OD =OD
</van>
=OA
=OD
HISTOR=CAL PERFORMANCE
UNDERLYING C=LLATERAL DESCRIPTION
1 MOS
=b>3 MOS
=td width="175" nowrap="" valign="bottom" style="width:131.05pt;b=rder:none;border-bottom:solid windowtext
1.0pt;padding:0in 5.4pt 0in 5=2E4ptheight:14.15pt")
6 MOS<=b>
Average Loan Balance =$,000s)
571
5
EFTA_R1_01355522
EFTA02362588
=OA
=0ACPR
8.4=
10.81
<=td> 11.11
Mortgage Type
Seasoned Pr=me 5/1 Hybrids
CDR
2.03
=OD 0.67
0.88<=p>
Wtd Avg Mortgage Coupon
3.010%
<=td> <=d width="161" nowrap="" valign="bottom" style="width:120.6pt;pad=ing:0in 5.4pt 0in 5.4ptheight:13.35pt">
SEV
16.39
16.39
</=d> Wtd Avg FICO Score
747<=o:p>
=OA
=OD
<=r style="height:13.35pt">
=OD
HPI Adj LTV
=OA 58.53%
=OD
Weighted Avg Loan Age=/o:p>
97
=td width="45" nowrap="" valign="bottom" style="width:34.1pt;padd=ng:0in 5.4pt 0in 5.4ptheight:13.35pt">
Owner Occupied
96.18
6
EFTA_R1_01355523
EFTA02362589
=/td> ad width="161" nowrap="" valign="bottom" style="width:120.6pt;pad=ing:0in 5.4pt Oin 5.4pt;height:13.35pt">
Top 1 =eo Concentration
CA 72%
=0A
=OD
Top 2 Geo Concentration
NY&n=sp; 5%
=OD
=/tr>
Always Current (24 mos)<=:p>
85.46%
<=td> <=d width="161" nowrap="" valign="bottom" style="width:120.6ptpad=ing:0in 5.4pt Oin 5.4pt;height:13.35pt">
*=II Investments are subject to risk, including possible loss of principal=2E
<1=>
*This message is a prod=ct of sales and trading and is not a research report=/p>
"Non-Agency bonds may have limited liquidity and c=ients should be aware that the seco=dary market for mortgage-
backed securities has experienced periods of illi=uidity and may do so in the future. Illiquidity means that there may
not=be any purchasers for your class of certificates. Although any cla=s of certificates may experience illiquidity, it is
more likely that class=s
*High=Yield Non-Agency bonds are speculative non-investment grade bonds that hav= higher
risk of default or other adverse credit events which are appropriat= for high risk investors only.
=td width="42" style="width:31.35pt;padding:0in Oin 0in Oin;height:13=2E8pt">
=nr>
=OA
=OD
<=pan style="font-size:11.0ptfont-family:"Calibri","sans=serif";color:#1F4970">
*** ALL OFFERS ARE=SUBJECT
7
EFTA_R1_01355524
EFTA02362590
US Onshore Clients — Blue Sky (U.S. S=ate Securities Law): Please confirm Blue Sky eligibility before soliciting=to a US
Onshore client by entering the CUSIP into the web tool located at:=0D
http://pscppvl.amer.jpmchase.net:8080/BlueSkyPage.html
<http://pscppvl.amer.jpmchase.net:8080/BlueSkyPage=2Ehtml> =/u> and review to see if your client's state of
residence is l=sted. If you receive 'NO SECURITY FOUND', 'NO STATES F=UND' or the security DOES NOT HAVE A CUSIP or
is not USD-denom=nated, then please contact your SM or local compliance officer and provide=the requested security
and client information. Please note that a suitab=lity review and other pre-trade procedures must still be
followed.=/span> </=:p>
=OA
This e=ail is confidential and subject to important disclaimers and conditions in=luding on offers for the purchase or sale
of securities, accuracy and comp=eteness of information, viruses, confidentiality, legal privilege, and leg=l entity
disclaimers, available at http://www.jpmorgan.com/pages/discl=sures/email.
8
EFTA_R1_01355525
EFTA02362591
Technical Artifacts (12)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
jeevacation@gmail.comPhone
2362584Phone
2362585Phone
2362586Phone
2362587Phone
2362588Phone
2362589Phone
2362590Phone
2362591URL
http://pscppvl.amer.jpmchase.net:8080/BlueSkyPage.htmlURL
http://pscppvl.amer.jpmchase.net:8080/BlueSkyPage=2EhtmlURL
http://www.jpmorgan.com/pages/discl=sures/emailRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.